
NYSEHealthcareMedical - Devices
أحدث البيانات المتاحة
87.43 US$
+1.92 US$ · +2.25%
Medtronic plc is a leading global medical technology enterprise that invents, develops, manufactures, and distributes an extensive range of device-based medical therapies. These solutions serve healthcare systems, clinicians, physicians, and patients across the world. The company's operations are categorized into several key portfolios: Cardiovascular Portfolio: This segment focuses on cardiac health, providing technologies for heart rhythm management, including implantable pacemakers, defibrillators, and monitoring systems, alongside cardiac ablation tools and remote patient software. It also addresses structural heart issues with products like aortic and pulmonary valves, surgical repair devices, and endovascular stent grafts, in addition to offerings for percutaneous coronary interventions (e.g., angioplasty balloons). Medical Surgical Portfolio: Offering a broad spectrum of surgical instruments and therapies, this division includes staples, vessel sealing devices, wound closure products, and electrosurgical equipment. It also pioneers surgical artificial intelligence and robotic-assisted platforms, alongside solutions for hernia repair, gynecology, lung conditions, minimally invasive gastrointestinal and hepatologic diagnostics, patient monitoring, airway management, ventilation therapies, and renal disease. Neuroscience Portfolio: This division delivers specialized products for a diverse group of medical professionals, such as spinal surgeons, neurosurgeons, neurologists, pain management specialists, and ENT experts. Its offerings span energy surgical instruments, advanced image-guided and intra-operative imaging systems, robotic guidance for spine procedures, and therapies targeting the brain's vasculature. Diabetes Operating Unit: Dedicated to diabetes management, this unit provides innovative solutions like insulin pumps and their associated consumables, continuous glucose monitoring (CGM) systems, and smart insulin pen technologies. Established in 1949, Medtronic plc maintains its corporate headquarters in Dublin, Ireland.
جلسة التداول العادية
88.19 US$
+2.68 US$ · +3.13%
تستخدم الأوقات اليومية المنطقة الزمنية ET. قد تتأخر بيانات السوق.
Medtronic plc is a leading global medical technology enterprise that invents, develops, manufactures, and distributes an extensive range of device-based medical therapies. These solutions serve healthcare systems, clinicians, physicians, and patients across the world. The company's operations are categorized into several key portfolios: Cardiovascular Portfolio: This segment focuses on cardiac health, providing technologies for heart rhythm management, including implantable pacemakers, defibrillators, and monitoring systems, alongside cardiac ablation tools and remote patient software. It also addresses structural heart issues with products like aortic and pulmonary valves, surgical repair devices, and endovascular stent grafts, in addition to offerings for percutaneous coronary interventions (e.g., angioplasty balloons). Medical Surgical Portfolio: Offering a broad spectrum of surgical instruments and therapies, this division includes staples, vessel sealing devices, wound closure products, and electrosurgical equipment. It also pioneers surgical artificial intelligence and robotic-assisted platforms, alongside solutions for hernia repair, gynecology, lung conditions, minimally invasive gastrointestinal and hepatologic diagnostics, patient monitoring, airway management, ventilation therapies, and renal disease. Neuroscience Portfolio: This division delivers specialized products for a diverse group of medical professionals, such as spinal surgeons, neurosurgeons, neurologists, pain management specialists, and ENT experts. Its offerings span energy surgical instruments, advanced image-guided and intra-operative imaging systems, robotic guidance for spine procedures, and therapies targeting the brain's vasculature. Diabetes Operating Unit: Dedicated to diabetes management, this unit provides innovative solutions like insulin pumps and their associated consumables, continuous glucose monitoring (CGM) systems, and smart insulin pen technologies. Established in 1949, Medtronic plc maintains its corporate headquarters in Dublin, Ireland.
نطاق اليوم
السعر الحالي 88.19 US$
نطاق 52 أسبوعًا
السعر الحالي 88.19 US$
تستخدم الأوقات اليومية المنطقة الزمنية ET. قد تتأخر بيانات السوق.
نقاط GoAI
شراء
تقييم
84
قيمة جذابة جدًا
المشاعر
65
صعودي
المخاطر
30
مخاطر متوسطة
الزخم
43
محايد
بحث كامل عن GoAI
تابع للاطلاع على أدلة ومحفزات ومخاطر أعمق.
Medtronic plc is a leading global medical technology enterprise that invents, develops, manufactures, and distributes an extensive range of device-based medical therapies. These solutions serve healthcare systems, clinicians, physicians, and patients across the world. The company's operations are categorized into several key portfolios: Cardiovascular Portfolio: This segment focuses on cardiac health, providing technologies for heart rhythm management, including implantable pacemakers, defibrillators, and monitoring systems, alongside cardiac ablation tools and remote patient software. It also addresses structural heart issues with products like aortic and pulmonary valves, surgical repair devices, and endovascular stent grafts, in addition to offerings for percutaneous coronary interventions (e.g., angioplasty balloons). Medical Surgical Portfolio: Offering a broad spectrum of surgical instruments and therapies, this division includes staples, vessel sealing devices, wound closure products, and electrosurgical equipment. It also pioneers surgical artificial intelligence and robotic-assisted platforms, alongside solutions for hernia repair, gynecology, lung conditions, minimally invasive gastrointestinal and hepatologic diagnostics, patient monitoring, airway management, ventilation therapies, and renal disease. Neuroscience Portfolio: This division delivers specialized products for a diverse group of medical professionals, such as spinal surgeons, neurosurgeons, neurologists, pain management specialists, and ENT experts. Its offerings span energy surgical instruments, advanced image-guided and intra-operative imaging systems, robotic guidance for spine procedures, and therapies targeting the brain's vasculature. Diabetes Operating Unit: Dedicated to diabetes management, this unit provides innovative solutions like insulin pumps and their associated consumables, continuous glucose monitoring (CGM) systems, and smart insulin pen technologies. Established in 1949, Medtronic plc maintains its corporate headquarters in Dublin, Ireland.
نطاق اليوم
السعر الحالي 88.19 US$
نطاق 52 أسبوعًا
السعر الحالي 88.19 US$
الربحية كنسبة مئوية من الإيرادات المعلنة.
الإيرادات
الدخل التشغيلي
صافي الدخل
| البند (USD) | السنة المالية 2026 | السنة المالية 2025 | السنة المالية 2024 | السنة المالية 2023 | السنة المالية 2022 |
|---|---|---|---|---|---|
| الإيرادات | 36.36 مليار USD | 33.54 مليار USD | 32.36 مليار USD | 31.23 مليار USD | 31.69 مليار USD |
| تكلفة البضاعة المباعة | 12.72 مليار USD | 11.63 مليار USD | 11.22 مليار USD | 10.72 مليار USD | 10.15 مليار USD |
| الربح الإجمالي | 23.64 مليار USD | 21.91 مليار USD | 21.15 مليار USD | 20.51 مليار USD | 21.54 مليار USD |
| البحث والتطوير | 2.87 مليار USD | 2.73 مليار USD | 2.74 مليار USD | 2.7 مليار USD | 2.75 مليار USD |
| مصاريف البيع والمصاريف العمومية والإدارية | 11.78 مليار USD | 10.85 مليار USD | 10.74 مليار USD | 10.42 مليار USD | 10.29 مليار USD |
| نفقات التشغيل | 17.18 مليار USD | 15.95 مليار USD | 16 مليار USD | 15.02 مليار USD | 15.79 مليار USD |
| مصاريف الفوائد | 715 مليون USD | 729 مليون USD | 719 مليون USD | 636 مليون USD | 553 مليون USD |
| الاستهلاك والإطفاء | 2.96 مليار USD | 2.86 مليار USD | 2.65 مليار USD | 2.7 مليار USD | 2.71 مليار USD |
| الدخل التشغيلي | 6.47 مليار USD | 5.96 مليار USD | 5.14 مليار USD | 5.49 مليار USD | 5.75 مليار USD |
| صافي الدخل | 4.8 مليار USD | 4.66 مليار USD | 3.68 مليار USD | 3.76 مليار USD | 5.04 مليار USD |
تم تحديث حقائق الشركة 8 أكتوبر 2026.
أحدث النتائج المعلنة
أحدث النتائج المعلنة
قد تتغير تقديرات المحللين الخارجيين، وهي ليست توصيات من GoAI.
متوسط الهدف
97.80 US$
ارتفاع محتمل بنسبة 10.90%| الإجراء | تاريخ النفاذ | تفاصيل | تاريخ التسجيل | تاريخ الدفع |
|---|---|---|---|---|
تقسيم الأسهم | 27 سبتمبر 1999 | 2:1 | — | — |
تقسيم الأسهم | 15 سبتمبر 1997 | 2:1 | — | — |
تقسيم الأسهم | 29 سبتمبر 1995 | 2:1 | — | — |
تقسيم الأسهم | 30 سبتمبر 1994 | 2:1 | — | — |
تقسيم الأسهم | 30 أغسطس 1991 | 2:1 | — | — |
تقسيم الأسهم | 31 أغسطس 1989 | 2:1 | — | — |
ساري 27 سبتمبر 1999
2:1
ساري 15 سبتمبر 1997
2:1
ساري 29 سبتمبر 1995
2:1
ساري 30 سبتمبر 1994
2:1
ساري 30 أغسطس 1991
2:1
ساري 31 أغسطس 1989
2:1
صناديق متداولة تفصح عن تعرضها لهذا السهم.
State Street SPDR S&P 500 ETF1557.T210.63 مليار0.16%129.41 ترليون JPY0.09%122,700 JP¥-0.57%
Vanguard Morningstar Total Stock Market ETFVTI3.7 مليار0.16%2.3 ترليون USD0.03%379.15 US$-0.49%
Vanguard S&P 500 ETFVOO3.09 مليار0.18%1.8 ترليون USD0.03%710.83 US$-0.49%
iShares Core S&P 500 ETFIVV1.46 مليار0.16%899.63 مليار USD0.03%776.79 US$-0.49%
State Street SPDR S&P 500 ETFSPY1.33 مليار0.16%819.04 مليار USD0.09%773.35 US$-0.50%
Vanguard Morningstar Value ETFVTV1.11 مليار0.42%262.4 مليار USD0.03%218.54 US$+0.15%
State Street Health Care Select Sector SPDR ETFXLV768.68 مليون1.78%43.11 مليار USD0.08%166.94 US$-1.11%
Vanguard Dividend Appreciation ETFVIG658.81 مليون0.50%132.4 مليار USD0.04%236.57 US$-0.18%
State Street SPDR S&P 500 ETF1557.T
Vanguard Morningstar Total Stock Market ETFVTI
Vanguard S&P 500 ETFVOO
iShares Core S&P 500 ETFIVV
State Street SPDR S&P 500 ETFSPY
Vanguard Morningstar Value ETFVTV
State Street Health Care Select Sector SPDR ETFXLV
Vanguard Dividend Appreciation ETFVIGالمحتوى المُنشأ بالذكاء الاصطناعي وبيانات السوق المتأخرة لأغراض معلوماتية وتعليمية فقط، ولا تُعد نصيحة استثمارية.